2/2 Partnership for the Advancement of Cancer Research: NMSU & Fred Hutch
2/2 促进癌症研究的伙伴关系:NMSU
基本信息
- 批准号:10601412
- 负责人:
- 金额:$ 78.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-30 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Partnership for the Advancement of Cancer Research: NMSU – Fred Hutch
Multiple PIs: Graciela A. Unguez, Mary O'Connell (NMSU) and Julian Simon, Beti Thompson (Fred Hutch)
[The content of the Overall Section is identical in the NMSU and Fred Hutch proposals.]
PROJECT SUMMARY/ABSTRACT
The U54 Partnership between New Mexico State University (NMSU), an Institution Serving Underserved
Health Disparities Populations and Underrepresented Students (ISUPS), and Fred Hutchinson Cancer
Research Center (Fred Hutch) a major cancer center, is a mature mutually beneficial partnership; the two
institutions worked together on a U56 (2002-2007) and two cycles of a U54 (2007 – 2018). In our 15-year
Partnership, we have accomplished many goals; for example, NMSU now has a strong cancer research
infrastructure and Fred Hutch is increasing its attention to health disparities research. Our overall goals for this
U54 cycle are to increase and maintain our excellence in the cancer research portfolio, cancer education, and
outreach and dissemination; further, we will expand our efforts to develop leaders in cancer research and
cancer health disparities research. Five specific aims will help us achieve our overall goals to: (1) Continue to
develop a diverse portfolio of robust cancer research projects that span clinical, basic, and population health
sciences; (2) Collaborate with regional community organizations that work with underrepresented populations
to reduce cancer health disparities; (3) Maintain, strengthen, and evaluate our effective research education
programs for current and future underrepresented scientists; (4) Continue to implement evidence-based
relevant cancer-related public health interventions within underrepresented communities; and (5) Expand the
scientific collaboration among U54 Partnership members and other faculty within the two institutions. To
achieve these aims, we have assembled a broad portfolio of innovative cancer research projects (two full
research projects and two pilot research projects) that each address an unmet regional need among
underrepresented populations. Recent emphasis on health disparities represents a shift in the focus of our
Partnership from basic to public health science research projects. These projects benefit from strong
community input. In addition to the four research projects, we propose five cores: Administrative, Planning and
Evaluation, Research Education About Cancer and Health (REACH), Outreach and Sustain Competitive
Cancer Early Stage Scientists (SuCCESS) Cores that promote the development of cancer research, education,
community collaboration, in-reach, and outreach. The Partnership has and will continue to play a unique and
critical role in both institutions' efforts to increase recruitment and retention of underrepresented individuals in
the biomedical research pipeline. Additionally, the Partnership has significantly increased cancer research
capacity at NMSU, while also increasing participation in health disparities research at Fred Hutch—both
institutions have benefited substantially from the Partnership.
癌症研究进展伙伴关系:NMSU - Fred Hutch
多名PI:Graciela A. Unguez,玛丽奥康奈尔(NMSU)和朱利安西蒙,贝蒂汤普森(弗雷德哈奇)
[The总体部分的内容在NMSU和Fred Hutch的提案中是相同的。
项目总结/摘要
新墨西哥州州立大学(NMSU)之间的U 54伙伴关系,一个服务不足的机构
健康差异人口和代表性不足的学生(IUPS)和弗雷德哈钦森癌症
研究中心(弗雷德哈奇)一个主要的癌症中心,是一个成熟的互利合作伙伴关系;
各机构在U 56(2002-2007)和U 54(2007 - 2018)的两个周期上进行了合作。在我们15年的
合作伙伴关系,我们已经完成了许多目标;例如,NMSU现在有一个强大的癌症研究
Fred Hutch正在增加对健康差异研究的关注。我们的总体目标是
U 54周期是增加和保持我们在癌症研究组合,癌症教育,
此外,我们将扩大努力,培养癌症研究领域的领导者,
癌症健康差异研究。五个具体目标将帮助我们实现我们的总体目标:(1)继续
开发一系列涵盖临床、基础和人群健康的强大癌症研究项目
(2)与从事代表性不足人口工作的区域社区组织合作
减少癌症健康差异;(3)保持,加强和评估我们有效的研究教育
为当前和未来代表性不足的科学家提供计划;(4)继续实施基于证据的
在代表性不足的社区开展相关的癌症相关公共卫生干预;以及(5)扩大
U 54伙伴关系成员和两个机构内的其他教师之间的科学合作。到
为了实现这些目标,我们已经收集了一个广泛的创新癌症研究项目组合(两个完整的
研究项目和两个试点研究项目),每一个项目都解决一个未得到满足的区域需求,
代表性不足的人群。最近对健康差距的强调表明,
从基础到公共卫生科学研究项目的伙伴关系。这些项目得益于强大的
社区投入。除了四个研究项目外,我们还提出了五个核心:行政,规划和
评估,关于癌症和健康的研究教育(REACH),推广和维持竞争力
癌症早期科学家(SuCCESS)核心,促进癌症研究,教育,
社区协作、内展和外展。该伙伴关系已经并将继续发挥独特和
在这两个机构努力增加征聘和保留任职人数不足的个人方面发挥关键作用,
生物医学研究管道。此外,该伙伴关系大大增加了癌症研究
能力在NMSU,同时也增加了参与健康差距研究在弗雷德哈奇-两者
各机构从伙伴关系中受益匪浅。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Julian A Simon其他文献
Julian A Simon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Julian A Simon', 18)}}的其他基金
Inhibition of B-Catenin Signaling for Treatment of Hepatocellular Carcinoma
抑制 B-连环蛋白信号转导治疗肝细胞癌
- 批准号:
8078972 - 财政年份:2010
- 资助金额:
$ 78.3万 - 项目类别:
Inhibition of B-Catenin Signaling for Treatment of Hepatocellular Carcinoma
抑制 B-连环蛋白信号转导治疗肝细胞癌
- 批准号:
7990951 - 财政年份:2010
- 资助金额:
$ 78.3万 - 项目类别:
Chemoprotection Against Aminoglycoside-Induced Ototoxicity
针对氨基糖苷类药物引起的耳毒性的化学保护
- 批准号:
8515203 - 财政年份:2009
- 资助金额:
$ 78.3万 - 项目类别:
Chemoprotection Against Aminoglycoside-Induced Ototoxicity
针对氨基糖苷类药物引起的耳毒性的化学保护
- 批准号:
7729834 - 财政年份:2009
- 资助金额:
$ 78.3万 - 项目类别:
Chemoprotection Against Aminoglycoside-Induced Ototoxicity
针对氨基糖苷类药物引起的耳毒性的化学保护
- 批准号:
8118073 - 财政年份:2009
- 资助金额:
$ 78.3万 - 项目类别:
Chemoprotection Against Aminoglycoside-Induced Ototoxicity
针对氨基糖苷类药物引起的耳毒性的化学保护
- 批准号:
8545455 - 财政年份:2009
- 资助金额:
$ 78.3万 - 项目类别:
Chemoprotection Against Aminoglycoside-Induced Ototoxicity
针对氨基糖苷类药物引起的耳毒性的化学保护
- 批准号:
7914280 - 财政年份:2009
- 资助金额:
$ 78.3万 - 项目类别:
Chemoprotection Against Aminoglycoside-Induced Ototoxicity
针对氨基糖苷类药物引起的耳毒性的化学保护
- 批准号:
8288091 - 财政年份:2009
- 资助金额:
$ 78.3万 - 项目类别:
Chemoprotection Against Aminoglycoside-Induced Ototoxicity
针对氨基糖苷类药物引起的耳毒性的化学保护
- 批准号:
8604242 - 财政年份:2009
- 资助金额:
$ 78.3万 - 项目类别:
Partnership for the Advancement of Cancer Research: NMSU-FHCRC (2 of 2)
促进癌症研究合作伙伴关系:NMSU-FHCRC(2 of 2)
- 批准号:
9342672 - 财政年份:2007
- 资助金额:
$ 78.3万 - 项目类别:
相似海外基金
partnership for the advancement of cancer research
促进癌症研究的伙伴关系
- 批准号:
8744900 - 财政年份:2013
- 资助金额:
$ 78.3万 - 项目类别:
Partnership for the Advancement of Cancer Research: NMSU-FHCRC (1 of 2)
促进癌症研究合作伙伴关系:NMSU-FHCRC(1 of 2)
- 批准号:
7933442 - 财政年份:2009
- 资助金额:
$ 78.3万 - 项目类别:
Partnership for the Advancement of Cancer Research: NMSU-FHCRC (2 of 2)
促进癌症研究合作伙伴关系:NMSU-FHCRC(2 of 2)
- 批准号:
7933474 - 财政年份:2009
- 资助金额:
$ 78.3万 - 项目类别:
Partnership for the Advancement of Cancer Research: NMSU-FHCRC (1 of 2)
促进癌症研究合作伙伴关系:NMSU-FHCRC(1 of 2)
- 批准号:
8538042 - 财政年份:2007
- 资助金额:
$ 78.3万 - 项目类别:
Partnership for the Advancement of Cancer Research: NMSU-FHCRC (1 of 2)
促进癌症研究合作伙伴关系:NMSU-FHCRC(1 of 2)
- 批准号:
8538038 - 财政年份:2007
- 资助金额:
$ 78.3万 - 项目类别:
Partnership for the Advancement of Cancer Research: NMSU-FHCRC (1 of 2)
促进癌症研究合作伙伴关系:NMSU-FHCRC(1 of 2)
- 批准号:
8741938 - 财政年份:2007
- 资助金额:
$ 78.3万 - 项目类别:
Partnership for the Advancement of Cancer Research: NMSU-FHCRC (1 of 2)
促进癌症研究合作伙伴关系:NMSU-FHCRC(1 of 2)
- 批准号:
9340968 - 财政年份:2007
- 资助金额:
$ 78.3万 - 项目类别:
Partnership for the Advancement of Cancer Research: NMSU-FHCRC (2 of 2)
促进癌症研究合作伙伴关系:NMSU-FHCRC(2 of 2)
- 批准号:
9342672 - 财政年份:2007
- 资助金额:
$ 78.3万 - 项目类别:
Partnership for the Advancement of Cancer Research: NMSU-FHCRC (2 of 2)
促进癌症研究合作伙伴关系:NMSU-FHCRC(2 of 2)
- 批准号:
7502658 - 财政年份:2007
- 资助金额:
$ 78.3万 - 项目类别:
Partnership for the Advancement of Cancer Research: NMSU-FHCRC (2 of 2)
促进癌症研究合作伙伴关系:NMSU-FHCRC(2 of 2)
- 批准号:
7410195 - 财政年份:2007
- 资助金额:
$ 78.3万 - 项目类别:














{{item.name}}会员




